67
Views
7
CrossRef citations to date
0
Altmetric
Original Article

The effect of catalase C262T gene polymorphism in susceptibility to ovarian cancer in Kermanshah province, Western Iran

ORCID Icon, ORCID Icon & ORCID Icon
Pages 562-566 | Received 30 Mar 2017, Accepted 06 Aug 2017, Published online: 08 Feb 2018

References

  • Ahn J, Ambrosone CB, Kanetsky PA, Tian C, Lehman TA, Kropp S, et al. 2006. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clinical Cancer Research 12:7063–7070.
  • Ambrosone CB. 2000. Oxidants and antioxidants in breast cancer. Antioxidants & Redox Signaling 2:903–917.
  • Aynali G, Doğan M, Sütcü R, Yüksel Ö, Yariktaş M, Ünal F, et al. 2013. Polymorphic variants of MnSOD Val16Ala, CAT-262 C < T and GPx1 Pro198Leu genotypes and the risk of laryngeal cancer in a smoking population. The Journal of Laryngology & Otology 127:997–1000.
  • Banerjee S, Gore M. 2009. The future of targeted therapies in ovarian cancer. The Oncologist 14:706–716.
  • Bast RC, Hennessy B, Mills GB. 2009. The biology of ovarian cancer: new opportunities for translation. Nature Reviews. Cancer 9:415–428.
  • Belotte J, Fletcher NM, Saed MG, Abusamaan MS, Dyson G, Diamond MP, et al. 2015. A single nucleotide polymorphism in catalase is strongly associated with ovarian cancer survival. PLoS One 10:e0135739.
  • Cerutti PA. 1985. Prooxidant states and tumor promotion. Science (New York, NY) 227:375–381.
  • Cramer DW, Liberman RF, Titus‐Ernstoff L, Welch WR, Greenberg ER, Baron JA, et al. 1999. Genital talc exposure and risk of ovarian cancer. International Journal of Cancer 81:351–356.
  • Crawford A, Fassett RG, Geraghty DP, Kunde DA, Ball MJ, Robertson IK, et al. 2012. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 501:89–103.
  • Ding G, Liu F, Shen B, Feng C, Xu J, Ding Q. 2012. The association between polymorphisms in prooxidant or antioxidant enzymes (myeloperoxidase, SOD2, and CAT) and genes and prostate cancer risk in the Chinese population of Han nationality. Clinical Genitourinary Cancer 10:251–255.
  • Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB. 2003. MnSOD polymorphism and breast cancer in a population-based case–control study. Cancer Letters 199:27–33.
  • Farawela H, Khorshied M, Shaheen I, Gouda H, Nasef A, Abulata N, et al. 2012. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt. Infection, Genetics and Evolution 12:1189–1194.
  • Forsberg L, Lyrenäs L, Morgenstern R, De Faire U. 2001. A common functional CT substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radical Biology and Medicine 30:500–505.
  • Funke S, Hoffmeister M, Brenner H, Chang-Claude J. 2009. Effect modification by smoking on the association between genetic polymorphisms in oxidative stress genes and colorectal cancer risk. Cancer Epidemiology and Prevention Biomarkers 18:2336–2338.
  • Geybels MS, Van Den Brandt PA, Van Schooten FJ, Verhage BA. 2015. Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention 24:178–186.
  • Goff BA, Mandel L, Muntz HG, Melancon CH. 2000. Ovarian carcinoma diagnosis. Cancer 89:2068–2075.
  • Hiss D. 2012. Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. Journal of Oncology 2012:737981 (23 pages). doi: 10.1155/2012/737981
  • Ho JC, Mak JC, Ho S, Ip MS, Tsang KW, Lam W, et al. 2006. Manganese superoxide dismutase and catalase genetic polymorphisms, activity levels, and lung cancer risk in Chinese in Hong Kong. Journal of Thoracic Oncology 1:648–653.
  • Karunasinghe N, Han DY, Goudie M, Zhu S, Bishop K, Wang A, et al. 2013. Prostate disease risk factors among a New Zealand cohort. Journal of Nutrigenetics and Nutrigenomics 5:339–351.
  • Kurman RJ, Shih I-M. 2011. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm. Human Pathology 42:918–931.
  • Mccullough LE, Santella RM, Cleveland RJ, Bradshaw PT, Millikan RC, North KE, et al. 2012. Polymorphisms in oxidative stress genes, physical activity, and breast cancer risk. Cancer Causes & Control: CCC 23:1949–1958.
  • Moradi MT, Yari K, Khodarahmi R. 2014. A novel, efficient, fast and inexpensive DNA extraction protocol from whole blood applicable for studying drug-DNA interaction. Journal of Reports in Pharmaceutical Sciences 3:80–84.
  • Muscat JE, Huncharek MS. 2008. Perineal talc use and ovarian cancer: a critical review. European Journal of Cancer Prevention 17:139.
  • Nguyen L, Cardenas-Goicoechea SJ, Gordon P, Curtin C, Momeni M, Chuang L, et al. 2013. Biomarkers for early detection of ovarian cancer. Women's Health 9:171–187.
  • Risch HA, Weiss NS, Lyon JL, Daling JR, Liff JM. 1983. Events of reproductive life and the incidence of epithelial ovarian cancer. American Journal of Epidemiology 117:128–139.
  • Saadat M, Saadat S. 2015. Genetic polymorphism of CAT C-262 T and susceptibility to breast cancer, a case–control study and meta-analysis of the literatures. Pathology & Oncology Research 21:433–437.
  • Sengüven B, Baris E, Oygur T, Berktas M. 2014. Comparison of methods for the extraction of DNA from formalin-fixed, paraffin-embedded archival tissues. International Journal of Medical Sciences 11:494–499.
  • Shen Y, Li D, Tian P, Shen K, Zhu J, Feng M, et al. 2015. The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis. Medicine 94:e679.
  • Siegel RL, Miller KD, Jemal A. 2016. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians 66:7–30.
  • Solé X, Guinó E, Valls J, Iniesta R, Moreno V. 2006. SNPStats: a web tool for the analysis of association studies. Bioinformatics (Oxford, England) 22:1928–1929.
  • Stoian A, Earar K, Budacu C, Voidazan S, Crauciuc A, Stoian M, et al. 2016. No association between antioxidant enzyme gene polymorphism and albuminuria in type 2 diabetes mellitus cases. Revista De Chimie 67:2355–2359.
  • Su S, He K, Li J, Wu J, Zhang M, Feng C, et al. 2015. Genetic polymorphisms in antioxidant enzyme genes and susceptibility to hepatocellular carcinoma in Chinese population: a case-control study. Tumour Biology 36:4627–4632.
  • Tefik T, Kucukgergin C, Sanli O, Oktar T, Seckin S, Ozsoy C. 2013. Manganese superoxide dismutase Ile58Thr, catalase C‐262T and myeloperoxidase G‐463A gene polymorphisms in patients with prostate cancer: relation to advanced and metastatic disease. BJU International 112:E406–E414.
  • Tsai S-M, Wu S-H, Hou M-F, Chen Y-L, Ma H, Tsai L-Y. 2012. Oxidative stress-related enzyme gene polymorphisms and susceptibility to breast cancer in non-smoking, non-alcohol-consuming Taiwanese women: a case-control study. Annals of Clinical Biochemistry 49:152–158.
  • Wang C-D, Sun Y, Chen N, Huang L, Huang J-W, Zhu M, et al. 2016. The role of catalase C262T gene polymorphism in the susceptibility and survival of cancers. Scientific Reports 6:26973 (8 pages). doi: 10.1038/srep26973

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.